COGT - Balance Sheet - Cogent Biosciences, Inc.

Current Liabilities	55.7 M
Accounts Payable	12 M
Short-Term Debt	1.56 M
Other Current Liabilities	42.1 M
Non-Current Liabilities	15.9 M
Long-Term Debt	15.9 M
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015
ASSETS
Cash & Cash Equivalents	98.2	53.2	139.9	219.7	242.2	37.4	55.7	28.3	41.3	90.5
Short Term Investments	188.9	212.5	119.4	0	0	0	22.9	12.7	27.2	0
Receivables	0	0	0	0	0	2.0	1.7	0.8	0.9	0.3
Inventory	0	0	0	0	0	0	0	75 K	0	0
Other Current Assets	9.4	5.1	5.7	5.9	5.4	2.3	1.5	0.6	0.3	0.3
Total Current Assets	296.5	270.8	265.0	222.6	244.9	40.6	81.0	42.4	69.7	91.1
PP&E	26.6	30.3	31.1	4.5	4.7	7.2	3.3	4.1	4.6	2.4
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	7.5	0	1.3	1.3	1.3	1.3	1.3	1.3	1.3
Other Long Term Assets	4.9	4.9	4.7	3.7	0	0.4	0.4	1.4	0	0
Other Assets	0	0	0	0	0	0	0	0	0	0
Total Assets	327.9	313.4	300.8	232.1	250.9	49.4	85.9	49.1	75.5	94.8
LIABILITIES
Accounts Payable	12.0	10.7	5.8	3.5	0.7	3.2	1.5	1.3	1.5	1.4
Short Term Debt	1.6	1.4	2.8	4.6	4.1	3.2	0	0	0	1
Other Current Liabilities	42.1	26.1	18.2	8.9	8.3	5.5	5.5	3.0	1.3	0.6
Total Current Liabilities	55.7	38.2	26.8	17.1	13.1	13.2	24.9	11.2	8.7	7.3
Long Term Debt	15.9	17.5	18.2	0.8	3.2	4.4	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	0.7	0.9	0.9	0.7
Total Liabilities	71.6	55.6	45.1	17.9	16.2	17.7	25.7	20.8	23.2	25.3
EQUITY
Common Stock	0.1	86 K	70 K	44 K	32 K	30 K	30 K	10 K	10 K	16 K
Retained Earnings	(859.5)	(603.6)	(411.2)	(271.0)	(198.7)	(123.9)	(92.1)	(51.3)	(25.8)	(7.7)
Other Accumulative Comprehensive Income/Loss	0.4	0.2	(0.1)	0	0	0	12 K	16 K	24 K	16 K
Total Equity	256.3	257.8	255.7	214.2	234.7	31.8	60.2	28.3	52.4	69.5
Total Liabilities and Equity	327.9	313.4	300.8	232.1	250.9	49.4	85.9	49.1	75.5	94.8
SHARES OUTSTANDING
Common Shares Outstanding	73.3	79.7	58.7	38.7	11.1	7.6	6.2	7.4	5.9	5.9

Free